Patents by Inventor Shouliang ZHANG

Shouliang ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11993527
    Abstract: An immobilized microbial agent for in situ restoration of contaminated sediments, composed of Hangjin clay 2 #-loaded conductive microorganisms, obtained by the following methods: 1) pretreating Hangjin clay 2 # to obtain particulate filler; 2) amplification culture of conductive microorganisms to a bacterial liquid to be inoculated, and adding the Hangjin clay 2 # pretreated in step 1 in a certain ratio, mixing under anaerobic conditions, removing the supernatant after standing, and obtaining the immobilized microbial agent; the conductive microorganisms are Geobacter sulfurreducens, Geobacter metallireducens and Shewanella. The invention also discloses a method for preparing the immobilized microbial agent and the application of in situ restoration of contaminated sediments.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: May 28, 2024
    Assignee: CHINESE RESEARCH ACADEMY OF ENVIRONMENTAL SCIENCES
    Inventors: Shouliang Huo, Jingtian Zhang, Beidou Xi, Chunzi Ma, Xiaochuang Li
  • Publication number: 20220127258
    Abstract: The present invention relates to aromatic ring or heteroaromatic ring compounds, a preparation method therefor and a medical use thereof. Particularly, the present invention relates to a compound as shown in general formula (I) and a preparation method therefor, a pharmaceutical composition comprising the compound and a use thereof as an agonist for a farnesoid X receptor (FXR). The compound and the pharmaceutical composition comprising the compound can be used for treating and/or preventing FXR activity-related diseases, for example, cholestatic symptoms, diabetes and complications thereof, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatosis heptitis (NASH), obesity or metabolic syndrome (diseases associated with dyslipidemia, diabetes, abnormally high body weight index), cardiovascular diseases and so on. The definition of each substituent in the general formula (I) is the same as that in the description.
    Type: Application
    Filed: January 17, 2020
    Publication date: April 28, 2022
    Inventors: Huijun YIN, Xu YAN, Libin ZONG, Jianxin SHI, Chunyan LIU, Shouliang ZHANG, Jiawei LU, Hao LI